BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1729889)

  • 1. Germ-line mosaicism for a valine-to-methionine substitution at residue 553 in the glycoprotein Ib-binding domain of von Willebrand factor, causing type IIB von Willebrand disease.
    Murray EW; Giles AR; Lillicrap D
    Am J Hum Genet; 1992 Jan; 50(1):199-207. PubMed ID: 1729889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recurring mutations at CpG dinucleotides in the region of the von Willebrand factor gene encoding the glycoprotein Ib binding domain, in patients with type IIB von Willebrand's disease.
    Lillicrap D; Murray EW; Benford K; Blanchette VS; Rivard GE; Wensley R; Giles AR
    Br J Haematol; 1991 Dec; 79(4):612-7. PubMed ID: 1772783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duplication of a methionine within the glycoprotein Ib binding domain of von Willebrand factor detected by denaturing gradient gel electrophoresis in a patient with type IIB von Willebrand disease.
    Ribba AS; Lavergne JM; Bahnak BR; Derlon A; Piétu G; Meyer D
    Blood; 1991 Oct; 78(7):1738-43. PubMed ID: 1912563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular study of von Willebrand disease: identification of potential mutations in patients with type IIA and type IIB.
    Piétu G; Ribba AS; de Paillette L; Chérel G; Lavergne JM; Bahnak BR; Meyer D
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):415-21. PubMed ID: 1420817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expressed full-length von Willebrand factor containing missense mutations linked to type IIB von Willebrand disease shows enhanced binding to platelets.
    Kroner PA; Kluessendorf ML; Scott JP; Montgomery RR
    Blood; 1992 Apr; 79(8):2048-55. PubMed ID: 1373334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type IIB mutation His-505-->Asp implicates a new segment in the control of von Willebrand factor binding to platelet glycoprotein Ib.
    Rabinowitz I; Randi AM; Shindler KS; Tuley EA; Rustagi PK; Sadler JE
    J Biol Chem; 1993 Sep; 268(27):20497-501. PubMed ID: 8376405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences.
    Randi AM; Rabinowitz I; Mancuso DJ; Mannucci PM; Sadler JE
    J Clin Invest; 1991 Apr; 87(4):1220-6. PubMed ID: 2010538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the gene encoding the alpha chain of platelet glycoprotein Ib in platelet-type von Willebrand disease.
    Miller JL; Cunningham D; Lyle VA; Finch CN
    Proc Natl Acad Sci U S A; 1991 Jun; 88(11):4761-5. PubMed ID: 2052556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of Val for Met at residue 239 of platelet glycoprotein Ib alpha in Japanese patients with platelet-type von Willebrand disease.
    Takahashi H; Murata M; Moriki T; Anbo H; Furukawa T; Nikkuni K; Shibata A; Handa M; Kawai Y; Watanabe K
    Blood; 1995 Feb; 85(3):727-33. PubMed ID: 7833477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in type IIA von Willebrand disease: a cysteine 509 to arginine substitution in the mature von Willebrand factor disrupts a disulphide loop involved in the interaction with platelet glycoprotein Ib-IX.
    Lavergne JM; De Paillette L; Bahnak BR; Ribba AS; Fressinaud E; Meyer D; Pietu G
    Br J Haematol; 1992 Sep; 82(1):66-72. PubMed ID: 1419804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib-IX receptor.
    Ware J; Dent JA; Azuma H; Sugimoto M; Kyrle PA; Yoshioka A; Ruggeri ZM
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2946-50. PubMed ID: 2011604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cosegregation of von Willebrand factor gene polymorphisms and possible germinal mosaicism in type IIB von Willebrand disease.
    Murray EW; Giles AR; Bridge PJ; Peake IR; Lillicrap DP
    Blood; 1991 Apr; 77(7):1476-83. PubMed ID: 2009368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of two point mutations in the von Willebrand factor gene of three families with the 'Normandy' variant of von Willebrand disease.
    Gaucher C; Mercier B; Jorieux S; Oufkir D; Mazurier C
    Br J Haematol; 1991 Aug; 78(4):506-14. PubMed ID: 1832934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of type IIB von Willebrand disease mutation Arg(545)Cys on platelet glycoprotein Ib binding--studies with recombinant von Willebrand factor.
    Inbal A; Kornbrot N; Harrison P; Randi AM; Sadler JE
    Thromb Haemost; 1993 Dec; 70(6):1058-62. PubMed ID: 8165601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pseudo-von Willebrand disease: a mutation in the platelet glycoprotein Ib alpha gene associated with a hyperactive surface receptor.
    Russell SD; Roth GJ
    Blood; 1993 Apr; 81(7):1787-91. PubMed ID: 8384898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain.
    Cooney KA; Nichols WC; Bruck ME; Bahou WF; Shapiro AD; Bowie EJ; Gralnick HR; Ginsburg D
    J Clin Invest; 1991 Apr; 87(4):1227-33. PubMed ID: 1672694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of recombinant von Willebrand factor corresponding to mutations in type IIA and type IIB von Willebrand disease.
    Ribba AS; Voorberg J; Meyer D; Pannekoek H; Pietu G
    J Biol Chem; 1992 Nov; 267(32):23209-15. PubMed ID: 1429668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrepancy between IIA phenotype and IIB genotype in a patient with a variant of von Willebrand disease.
    Ribba AS; Christophe O; Derlon A; Cherel G; Siguret V; Lavergne JM; Girma JP; Meyer D; Pietu G
    Blood; 1994 Feb; 83(3):833-41. PubMed ID: 8298143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant von Willebrand factor Arg578-->Gln. A type IIB von Willebrand disease mutation affects binding to glycoprotein Ib but not to collagen or heparin.
    Randi AM; Jorieux S; Tuley EA; Mazurier C; Sadler JE
    J Biol Chem; 1992 Oct; 267(29):21187-92. PubMed ID: 1400429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of type 2b von Willebrand disease mutations: implications for the mechanism of von Willebrand factor binding to platelets.
    Cooney KA; Ginsburg D
    Blood; 1996 Mar; 87(6):2322-8. PubMed ID: 8630394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.